Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verapamil in Newly Diagnosed Type 1 Diabetes in Children and Adolescents
NCT07804849Phase 3Recruiting
- Sponsor
- Ain Shams University
- Start
- Aug 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
A Phase 3 trial of verapamil in type 1 diabetes mellitus (T1D), sponsored by Ain Shams University. Started Aug 2026; status: recruiting.
02
Drugs
verapamil
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT07804849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07804849.